Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
Holding NMRA?
Track your performance easily

Neumora Therapeutics, Inc. (NMRA) Balance Sheet

135 Followers

Neumora Therapeutics, Inc. Balance Sheet

Neumora Therapeutics, Inc.'s total assets for Q2 2024 were £404.47M, a decrease of -10.16% from the previous quarter. NMRA total liabilities were £23.21M for the fiscal quarter, a -9.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22
Total Assets
£ 496.19M£ 426.23M
Total Liabilities
£ 27.12M£ 29.40M
Total Equity Gross Minority
£ 469.08M£ 396.84M
Total Capitalization
£ 470.93M£ 396.84M
Preferred Stock Equity
--
Capital Lease Obligations
--
Currency in GBP

Neumora Therapeutics, Inc. Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis